IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q4 2021 Holdings

Filed 2022-02-14 | 6 holdings | $217.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icosavax IncCOM45114M109$80.3K3,510,22837.0%
Jasper Therapeutics IncCOM471871103$45.9K5,852,98221.1%
Talaris Therapeutics IncCOM87410C104$44.8K2,932,60620.6%
Ventyx Biosciences Inc(VTYX)COM92332V107$18.1K910,3068.3%
Elevation Oncology IncCOM28623U101$14.3K2,370,1426.6%
Kezar Life Sciences IncCOM49372L100$13.9K828,7116.4%